Screening for controlled substance abuse in an interventional pain management setting: Evaluation of an assessment tool

Pain Physician

Volumn 6, Issue 4, 2003, Pages 425-433

  Manchikanti, Laxmaiah ^a,d   Singh, Vijay ^b   Damron, Kim S ^c   Beyer, Carla D ^c   Pampati, Vidyasagar ^a  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b Pain Diagnostics Associates   (United States)

^c Ambulatory Surgery Center   (United States)

^d NONE   (United States)

Author keywords

Assessment tool; Controlled substances; Substance abuse; Substance abuse assessment; Substance dependence

Indexed keywords

ILLICIT DRUG; OPIATE;

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG DEPENDENCE; DRUG USE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL PARAMETERS; PAIN; PATIENT ATTITUDE; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SUBSTANCE ABUSE; VALIDATION PROCESS;

EID: 0345688031     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Epidemiologic Trends in Drug Abuse Advance Report. Community Epidemiology Work Group. National Institutes of Health. National Institute on Drug Abuse. CEWG Publications, Rockville, Maryland, June 2001.
2. The D.A.W.N. Report. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA); Jan 2003.
3. Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: The case of prescription drugs with abuse potential. Substance Use & Misuse 2001; 36:1275-1296.
4. Batten HL, Prottas JM, Horgan CM et al. Drug Services Research Survey. Phase II Final Report. Submitted to the National Institute on Drug Abuse. Institute for Health Policy, Brandeis University, Waltham, MA February 12, 1993.
5. 1 National Household Survey on Drug Abuse (NHSDA). DHHS Publication No. (SMA) 02-3758. Rockville, MD: Department of Health and Human Services; Substance Abuse and Mental Health Services Administration, 2002.
6. The NHSDA Report. Nonmedical Use of Prescription-Type Drugs among Youths and Young Adults. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA), Jan 2003.
7. Manchikanti L, Pampati V, Damron K et al. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician 2003;6:173-178.
8. Lewin ICF. Analysis of Prescription Monitoring Programs. Prepared for Hoffman-LaRoche by Lewin ICF. Washington DC, April 26, 1991.
9. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8: 77-85.
10. Manchikanti L, Pampati V, Damron K et al. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001;4:358-365.
11. Manchikanti L, Pampati V, Damron K. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J KY Med Assoc 2003; in press.
12. Manchikanti L, Beyer C, Damron K et al. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management. Pain Physician 2003; 6:281-286.
13. Polatin PB, Kinney RK, Gatchel RJ et al. Psychiatric illness and chronic low back pain: The mind and the spine - which goes first? Spine 1993; 18:66-71.
14. Chabal C, Erjavec MK, Jacobson L et al. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain 1997; 13:150-155.
15. Atluri S, Boswell M, Hansen H et al. Guidelines for the use of controlled substances in the management of chronic pain. Pain Physician 2003; 6:233-257.
16. Atluri S, Sudarshan G. A screening tool to determine the risk of prescription opioid abuse among patients with chronic non-malignant pain. Pain Physician 2002; 5: 447-448.
17. Manchikanti L, Brown K, Singh V. National All Schedules Prescription Electronic Reporting Act NASPER: Balancing substance abuse and medical necessity in interventional pain management. Pain Physician 2002; 5:294-319.
18. Anthony JC. Drug use and dependence outside medical settings: Recent epidemiological evidence. TEN 2000; 2:54-58.
19. Joranson DE, Ryan KM, Gilson AM et al. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283:1710-1714.
20. Drug Enforcement Administration, National Alliance for Model State Drug Laws. Diversion and abuse of prescription drugs: A closer look at state prescription monitoring programs. Washington, DC: Drug Enforcement Administration, 2000. http://www.deadiversion.usdoj.gov/ pubs/program/prescription_monitor/index.html).
21. Kentucky Drug Threat Assessment. National Drug Intelligence Center and Kentucky State Police. Product No. 2002-SO382 KY-001, July 2002.
22. The KASPER Program. The KY Cabinet for Health Services. Department for Public Health. dphdrugcontrolμail.state.ky.u. s.
23. Houck LK. The Drug Enforcement Administration, Controlled Substances and Pain Management. http://www.deadiversion.usdoj.gov/pubs/ nwslttr/spec2001/ page10.htm
24. Robertson JR, treasure W. Benzodiazepine abuse. Nature and extent of the problem. CNS Drugs 1996; 5:137-146.
25. Gelkopf M, Bleich A, Hayward R et al. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: A 1-year prospective study in an Israeli clinic. Drug Alcohol Depend 1999; 55:63-68.
26. American Medical Association. Curtailing prescription drug abuse while preserving therapeutic use: American Medical Association recommendations for drug control policy. In Wilford BB (ed). Balancing the Response to Prescription Drug Abuse. American Medical Association, Chicago, 1990, pp 273-298.
27. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998; 16:355-363.
28. . Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996; 11:163-171.
29. Coambs R, Jarry JL, Santhiapillai AC et al. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res Manage 1996; 1:155-162.
30. Passik SD, Whitcomb L, Dodd S et al. Pain outcomes in long-term treatment with opioids: Preliminary results with a newly developed physician checklist. The fourth conference on pain management and chemical dependency. Washington, DC; 2000.
31. Fishman SM, Wilsey B, Yang J et al. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage 2000; 20:293-307.
32. Sees KL, Clark W. Opioid use in the treatment of chronic pain: Assessment of addiction. J Pain Symptom Manage 1993; 8: 257-264.
33. Miotto K, Compton P, Ling W et al. Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996; 37:223-235.
34. Pancratz L, Hickman DH, Toth S. The identification and management of drug-seeking behavior in a medical center. Drug Alcohol Depend 1989; 24:115-118.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
36. Kleber H. The nosology of abuse and dependence. J Psychiatr Res 1990; 24:57-64.
37. Graham AW, Schultz TK, Mayo-Smith MF et al (eds). Principles of Addiction Medicine, Third Edition. American Society of Addiction Medicine (ASAM) Publications, Chevy Chase, 2003.
38. Portenoy RK. Opioid therapy for chronic non-malignant pain: Current status. In Fields HL, Liebeskind JC (eds). Progress in Pain Research and Management, Vol. 1. IASP Press, Seattle, 1994:247-287.
39. Weissman DE, Haddox JD. Opioid pseudoaddiction: An iatrogenic syndrome. Pain 1989; 36:363-366.
40. Fishbain DA. Report on the prevalence of drug/alcohol abuse and dependence in chronic pain patients (CPPs). Subst Use Misuse 1996; 31:945-946.
41. Haller DL, Butler S. Use and abuse of prescription and recreational drugs by chronic pain patients. in Harris LS (ed). Problems of drug dependence, 1990. Washington DC: GPO, 1991: 456-457.
42. Chabal C, Jacobson L, Chaney EF et al. Narcotics for chronic pain: Yes or no? A useless dichotomy. Am Pain Soc J 1992; 1: 276-281.
43. Chabal C, Jacobson L, Chaney EF et al. The psychosocial impact of opioid treatment. Am Pain Soc J 1992; 1:289-291.
44. Chabal C, Jacobson L, Mariano A et al. Chronic nonmalignant pain: A syndrome not a diagnosis. Am Pain Soc J 1994; 3: 138-139.
45. Portenoy R. Chronic opioid therapy for nonmalignant pain: From models to practice. Am Pain Soc J 1992; 3:285-288.
46. Waddell G, McCulloch JA, Kummel E et al. Non-organic physical signs in low back pain. Spine 1980; 5:117-125.
47. Waddell G, Main CJ, Morris EW et al. Chronic low back pain, psychological distress, and illness behavior. Spine 1984; 9: 209-213.
48. Main CJ, Waddell G. Behavior response to examination. A reappraisal of the interpretation of "nonorganic signs." Spine 1998; 23:2367-2371.
49. Waddell G, Bircher M, Finlayson D et al. Symptoms and signs: Physical disease or illness behavior? BMJ 1984; 289:739-741.
50. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In Kitahata LM, Collins D (eds). Narcotic analgesics in anesthesiology. Williams and Wilkins, Baltimore, 1982.
51. Magruder-Habib K, Saltz EE, Barron PM. Age related patterns of alcoholism among beterands in ambulatory care. Hospital and Community Psychiatry 1986; 37:1251-1255.
52. Williams M. Alcohol and the elderly: An overview. Alcohol Health Res World 1984; 8:3-12.